Venus Concept Inc. (VERO)
USD 2.47
(3.35%)
USD 2.47
(3.35%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 93.65 Million USD | -25.3% |
| 2022 | 125.37 Million USD | -18.52% |
| 2021 | 153.86 Million USD | -4.15% |
| 2020 | 160.52 Million USD | -16.01% |
| 2019 | 191.12 Million USD | 517.08% |
| 2018 | 30.97 Million USD | -6.06% |
| 2017 | 32.97 Million USD | 69.09% |
| 2016 | 19.49 Million USD | -26.36% |
| 2015 | 26.47 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 79.75 Million USD | -6.26% |
| 2024 Q1 | 85.07 Million USD | -9.16% |
| 2023 Q3 | 98.92 Million USD | -6.82% |
| 2023 Q2 | 106.15 Million USD | -5.9% |
| 2023 Q1 | 112.81 Million USD | -10.02% |
| 2023 Q4 | 93.65 Million USD | -5.32% |
| 2023 FY | 93.65 Million USD | -25.3% |
| 2022 Q4 | 125.37 Million USD | 3.94% |
| 2022 Q1 | 144.42 Million USD | -6.14% |
| 2022 FY | 125.37 Million USD | -18.52% |
| 2022 Q2 | 132.75 Million USD | -8.08% |
| 2022 Q3 | 120.62 Million USD | -9.13% |
| 2021 Q1 | 148.75 Million USD | -7.33% |
| 2021 Q4 | 153.86 Million USD | 11.37% |
| 2021 Q3 | 138.15 Million USD | -6.19% |
| 2021 FY | 153.86 Million USD | -4.15% |
| 2021 Q2 | 147.27 Million USD | -1.0% |
| 2020 FY | 160.52 Million USD | -16.01% |
| 2020 Q4 | 160.52 Million USD | 9.19% |
| 2020 Q3 | 147.01 Million USD | -2.59% |
| 2020 Q2 | 150.92 Million USD | -2.79% |
| 2020 Q1 | 155.25 Million USD | -18.77% |
| 2019 Q2 | 23.17 Million USD | -22.29% |
| 2019 Q1 | 29.82 Million USD | -3.72% |
| 2019 Q3 | 20.74 Million USD | -10.47% |
| 2019 FY | 191.12 Million USD | 517.08% |
| 2019 Q4 | 191.12 Million USD | 821.14% |
| 2018 FY | 30.97 Million USD | -6.06% |
| 2018 Q1 | 25.88 Million USD | -21.5% |
| 2018 Q3 | 37.73 Million USD | 29.95% |
| 2018 Q2 | 29.04 Million USD | 12.21% |
| 2018 Q4 | 30.97 Million USD | -17.92% |
| 2017 Q2 | 18.15 Million USD | 0.0% |
| 2017 Q4 | 32.97 Million USD | 105.57% |
| 2017 Q3 | 16.03 Million USD | -11.64% |
| 2017 FY | 32.97 Million USD | 69.09% |
| 2016 FY | 19.49 Million USD | -26.36% |
| 2016 Q4 | 19.49 Million USD | 0.0% |
| 2015 FY | 26.47 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 31.36 Million USD | -198.584% |
| BrainsWay Ltd. | 62.97 Million USD | -48.723% |
| Cerus Corporation | 197.74 Million USD | 52.64% |
| Envoy Medical, Inc. | 7.64 Million USD | -1125.838% |
| electroCore, Inc. | 16.38 Million USD | -471.514% |
| Helius Medical Technologies, Inc. | 7.69 Million USD | -1117.551% |
| IceCure Medical Ltd | 16.41 Million USD | -470.713% |
| Inogen, Inc. | 326.19 Million USD | 71.289% |
| OrthoPediatrics Corp. | 449.58 Million USD | 79.169% |
| Lucid Diagnostics Inc. | 27.27 Million USD | -243.432% |
| Monogram Orthopaedics, Inc. | 16.57 Million USD | -464.895% |
| MaxCyte, Inc. | 268.27 Million USD | 65.09% |
| NeuroOne Medical Technologies Corporation | 8.09 Million USD | -1056.606% |
| Nexalin Technology, Inc. | 3.63 Million USD | -2478.639% |
| Orthofix Medical Inc. | 925.31 Million USD | 89.879% |
| PAVmed Inc | 33.11 Million USD | -182.78% |
| Rapid Micro Biosystems, Inc. | 143.45 Million USD | 34.714% |
| RxSight, Inc. | 182.55 Million USD | 48.697% |
| Sight Sciences, Inc. | 166.65 Million USD | 43.802% |
| SI-BONE, Inc. | 230.42 Million USD | 59.356% |
| TELA Bio, Inc. | 78.04 Million USD | -19.995% |
| Treace Medical Concepts, Inc. | 251.9 Million USD | 62.822% |
| Vivos Therapeutics, Inc. | 10.73 Million USD | -772.824% |
| Acutus Medical, Inc. | 53.96 Million USD | -73.562% |
| Talis Biomedical Corporation | 98.34 Million USD | 4.765% |
| Spectral AI, Inc. | 10.69 Million USD | -775.926% |
| Nano-X Imaging Ltd. | 218.64 Million USD | 57.167% |
| CVRx, Inc. | 115.22 Million USD | 18.724% |
| DIH Holding US, Inc. Warrants | 58.66 Million USD | -59.653% |
| PetVivo Holdings, Inc. | 3.11 Million USD | -2906.305% |
| Bioventus Inc. | 810.91 Million USD | 88.451% |
| TriSalus Life Sciences, Inc. | 25.72 Million USD | -264.058% |
| LivaNova PLC | 2.42 Billion USD | 96.145% |
| 908 Devices Inc. | 202.98 Million USD | 53.861% |
| Alphatec Holdings, Inc. | 805.2 Million USD | 88.369% |
| Nemaura Medical Inc. | 14.56 Million USD | -543.085% |
| NeuroPace, Inc. | 107.65 Million USD | 13.002% |
| LENSAR, Inc. | 69.58 Million USD | -34.589% |
| Apyx Medical Corporation | 79.24 Million USD | -18.19% |
| Cutera, Inc. | 346.29 Million USD | 72.955% |
| STRATA Skin Sciences, Inc. | 42.01 Million USD | -122.901% |
| BioSig Technologies, Inc. | 1.79 Million USD | -5108.788% |
| Anika Therapeutics, Inc. | 270.63 Million USD | 65.394% |
| ClearPoint Neuro, Inc. | 42.66 Million USD | -119.531% |
| Integra LifeSciences Holdings Corporation | 3.78 Billion USD | 97.524% |
| Axonics, Inc. | 719.92 Million USD | 86.991% |
| Outset Medical, Inc. | 313.8 Million USD | 70.155% |
| IRIDEX Corporation | 34.43 Million USD | -171.965% |
| PROCEPT BioRobotics Corporation | 404.71 Million USD | 76.859% |
| IRadimed Corporation | 92.15 Million USD | -1.625% |
| Tivic Health Systems, Inc. | 5.25 Million USD | -1682.528% |
| INVO Bioscience, Inc. | 20.88 Million USD | -348.367% |
| Telesis Bio, Inc. | 70.41 Million USD | -33.01% |
| Viemed Healthcare, Inc. | 154.1 Million USD | 39.226% |
| Varex Imaging Corporation | 1.24 Billion USD | 92.505% |
| Quipt Home Medical Corp. | 247.4 Million USD | 62.146% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -905.951% |
| Pulmonx Corporation | 178.95 Million USD | 47.665% |
| Dynatronics Corporation | 25.94 Million USD | -261.033% |
| Modular Medical, Inc. | 13.8 Million USD | -578.308% |
| ReShape Lifesciences Inc. | 10.72 Million USD | -773.068% |
| Semler Scientific, Inc. | 78.06 Million USD | -19.969% |
| InMode Ltd. | 863.28 Million USD | 89.151% |
| Bruker Corporation | 4.24 Billion USD | 97.796% |
| Cytosorbents Corporation | 53.26 Million USD | -75.841% |
| DexCom, Inc. | 6.26 Billion USD | 98.505% |
| Align Technology, Inc. | 6.08 Billion USD | 98.461% |
| Viveve Medical, Inc. | 25.91 Million USD | -261.417% |
| ZimVie Inc. | 1.2 Billion USD | 92.23% |
| Movano Inc. | 9.42 Million USD | -894.098% |
| Cytek Biosciences, Inc. | 497.66 Million USD | 81.181% |
| Nexalin Technology, Inc. | 3.63 Million USD | -2478.639% |
| DIH Holdings US, Inc. Class A Common Stock | 58.66 Million USD | -59.653% |
| Tandem Diabetes Care, Inc. | 952.65 Million USD | 90.169% |
| Profound Medical Corp. | 43.68 Million USD | -114.378% |
| Insulet Corporation | 2.58 Billion USD | 96.382% |
| enVVeno Medical Corporation | 48.63 Million USD | -92.565% |
| Surmodics, Inc. | 185.73 Million USD | 49.576% |
| iCAD, Inc. | 41.41 Million USD | -126.119% |
| Nuwellis, Inc. | 9.77 Million USD | -858.588% |
| Biotricity, Inc. | 5.94 Million USD | -1475.97% |
| iRhythm Technologies, Inc. | 433.14 Million USD | 78.378% |
| Aethlon Medical, Inc. | 8.24 Million USD | -1035.753% |
| InspireMD, Inc. | 47.64 Million USD | -96.575% |
| PAVmed Inc. | 33.11 Million USD | -182.78% |
| BIOLASE, Inc. | 35.1 Million USD | -166.813% |
| Beyond Air, Inc. | 56.96 Million USD | -64.418% |
| FONAR Corporation | 214.24 Million USD | 56.287% |
| AxoGen, Inc. | 196.82 Million USD | 52.418% |
| Vivani Medical, Inc. | 45.79 Million USD | -104.498% |
| Tactile Systems Technology, Inc. | 281.43 Million USD | 66.723% |
| Inari Medical, Inc. | 674.23 Million USD | 86.11% |
| UFP Technologies, Inc. | 404.13 Million USD | 76.826% |
| QT Imaging Holdings, Inc. | 23.39 Million USD | -300.255% |
| Heart Test Laboratories, Inc. | 9.5 Million USD | -885.509% |
| Tenon Medical, Inc. | 6.34 Million USD | -1376.028% |
| Autonomix Medical, Inc. Common Stock | 9.4 Million USD | -895.578% |
| Co-Diagnostics, Inc. | 103.64 Million USD | 9.642% |
| AdaptHealth Corp. | 4.61 Billion USD | 97.973% |
| Sintx Technologies, Inc. | 15.36 Million USD | -509.528% |
| NanoVibronix, Inc. | 6.67 Million USD | -1303.266% |
| Quanterix Corporation | 425.01 Million USD | 77.964% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -905.951% |
| Sensus Healthcare, Inc. | 53.72 Million USD | -74.315% |
| Pacific Biosciences of California, Inc. | 1.74 Billion USD | 94.636% |
| TransMedics Group, Inc. | 706.04 Million USD | 86.735% |
| ReWalk Robotics Ltd. | 63.19 Million USD | -48.205% |
| NeuroMetrix, Inc. | 21.42 Million USD | -337.136% |
| Hyperfine, Inc. | 94.19 Million USD | 0.579% |
| Establishment Labs Holdings Inc. | 268.64 Million USD | 65.138% |
| Biomerica, Inc. | 9.25 Million USD | -912.038% |
| Bone Biologics Corporation | 3.73 Million USD | -2405.616% |
| AVITA Medical, Inc. | 144.33 Million USD | 35.116% |
| Bluejay Diagnostics, Inc. | 4.86 Million USD | -1823.66% |
| Silk Road Medical, Inc | 265.3 Million USD | 64.7% |